Results 171 to 180 of about 129,195 (289)

Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF‐Fused Chiasmatic Glioma

open access: yesPediatric Blood &Cancer, Volume 73, Issue 6, June 2026.
ABSTRACT Infants, less than 1 year, with chiasmatic gliomas (ICG) present a major therapeutic challenge due to large tumor size, decreased vision, rapid progression, and poor response to vincristine/carboplatin chemotherapy. The majority have a BRAF fusion, which may respond to downstream MEK inhibitors but response time is slow. There are no safety or
Helen Toledano   +7 more
wiley   +1 more source

Eicosapentaenoic Acid Suppresses Tumor Growth and Enhances Chemosensitivity via AKT/mTOR Signaling in Uterine Serous Carcinoma. [PDF]

open access: yesCancers (Basel)
Zhang H   +9 more
europepmc   +1 more source

PD‐L1‐Inhibitor‐Associated Hidradenitis Suppurativa

open access: yes
Journal of Cutaneous Pathology, EarlyView.
Annie Jin   +2 more
wiley   +1 more source

Gemcitabine, Docetaxel, Melphalan, Carboplatin as Part of Sequential Cycles of High‐Dose Chemotherapy With Autologous Hematopoietic Stem‐Cell Rescue for Multiply Relapsed/Refractory Pediatric Germ Cell Tumors

open access: yesPediatric Blood &Cancer, Volume 73, Issue 6, June 2026.
ABSTRACT Although most malignant germ cell tumors (GCTs) are highly curable with cisplatin‐based therapy, options for patients with multiply relapsed/refractory disease remain limited. For this population, we report the first pediatric use of gemcitabine, docetaxel, melphalan, and carboplatin (GemDMC) as part of sequential cycles of high‐dose ...
Maria Frost   +10 more
wiley   +1 more source

Comparative carboplatin pharmacokinetics in four different avian species [PDF]

open access: yes, 2013
Antonissen, Gunther   +6 more
core   +1 more source

Evaluation of a New, Community‐Based Screening Program to Detect Hearing Loss in Adult Childhood Cancer Survivors in Switzerland: Findings From the HEAR Study

open access: yesPediatric Blood &Cancer, Volume 73, Issue 6, June 2026.
ABSTRACT Background Childhood cancer survivors (CCS) have an increased risk of long‐term health complications, including treatment‐related hearing loss. Although early detection is important, many adult survivors do not attend hearing screenings in clinical centers because visits can be logistically or emotionally burdensome.
Philippa Jörger   +9 more
wiley   +1 more source

Distortion product otoacoustic emission (DPOAE) reveals hearing loss up to 16 kHz in pediatric chemotherapy patients. [PDF]

open access: yesSci Rep
Hecker DJ   +11 more
europepmc   +1 more source

The Use of FN‐Silk Networks as Extracellular Matrix‐Mimicking Support for 3D In Vitro Breast Cancer Models Improved the Model's Reproducibility in Drug Sensitivity

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 2, June 2026.
Chemotherapy treatment experiments were conducted on three breast cancer cell lines cultured in 2D, spheroids, and the novel 3D support: FN‐silk networks. The breast cancer cells cultured in FN‐silk networks were generally less sensitive to the drugs tested, compared to 2D cultures, potentially giving higher clinical relevance.
Suha Karrani   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy